• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Heart Failure/Congestive Heart Failure (4446); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/01/2015
Event Type  Death  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The additional patient effects reported in the article(s) are captured under a separate medwatch report.Date of death is an estimated date.Article titled "edge-to-edge transcatheter mitral valve repair versus optimal medical treatment in nonresponders to cardiac resynchronization therapy: the mitra-crt trial.".
 
Event Description
This is filed to report death and serious injuries.This study was a single-center randomized, controlled and open-label trial comparing edge-to-edge transcatheter mitral valve repair (tmvr) with the mitraclip device to optimal medical treatment (omt) in nonresponders to cardiac resynchronization therapy (crt) with dilated cardiomyopathy (dcm) and functional mitral regurgitation (fmr).The study included 31 patients: 15 in the control and 16 in the tmvr group.Regarding the safety end point, no procedure related serious adverse events were observed in the tvmr group.Complications noted during 12 month follow-up included: moderate to severe mr, rehospitalization due to heart failure and death (all-cause and cardiovascular).In conclusion, in patients with dcm and crt who were clinically nonresponders and present fmr >2, ¿edge-to-edge¿ tmvr, as compared with omt was associated with a reduction of the combined end point of cardiovascular death, heart transplantation and chronic heart failure (chf) hospitalizations and a reduction in the number of chf hospitalizations and the need of diuretic treatment escalation at 1 year.Details are listed in the attached article titled, "edge-to-edge transcatheter mitral valve repair versus optimal medical treatment in nonresponders to cardiac resynchronization therapy: the mitra-crt trial.".
 
Manufacturer Narrative
The device was not returned for analysis and a review of the lot history record and similar complaint review could not be performed as the part and lot number regarding the complaint device was not provided.The investigation was unable to determine a cause for the reported deaths.Death is listed in the instructions for use as known possible complications associated with mitraclip procedures.The reported hospitalization was a result of case-specific circumstance.There is no indication of a product issue with respect to manufacture, design, or labeling.The additional patient effects reported in the article(s) are captured under a separate medwatch report.Attachment; article titled "edge-to-edge transcatheter mitral valve repair versus optimal medical treatment in nonresponders to cardiac resynchronization therapy: the mitra-crt trial." a2: mean age a3: majority gender b2 - date of death is an estimated date.B3: date of event was estimated as 01/01/2015 d4: the udi is unknown as the part and lot numbers were not provided d6a: date of implant was estimated as (b)(6) 2015.B3: date of event was corrected to 01/01/2015.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15666674
MDR Text Key302393835
Report Number2135147-2022-01776
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/30/2022
Initial Date FDA Received10/25/2022
Supplement Dates Manufacturer Received10/28/2022
Supplement Dates FDA Received11/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age70 YR
Patient SexMale
-
-